Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Oxazolidin-2-one and thiazolidin-2-one derivatives for use as EP4 receptor agonists in the treatment of glaucoma

Oxazolidin-2-one and thiazolidin-2-one derivatives for use as EP4 receptor agonists in the treatment of glaucoma

US Patent 7109223 · Granted Sep 19, 2006

Estimated economic value: $69,070,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Fluoro beta-carboline compounds2025
Small molecule inhibitors of KRAS G12C mutant2025
Small molecule inhibitors of KRAS G12C mutant2025
Substituted tetrahydroquinolin compounds as indoleamine 2,3-dioxygenase (IDO) in2025
Substituted piperazine amide compounds as indoleamine 2,3-dioxygenase (IDO) inhi2025
Aryl sulfonamides as BLT1 antagonists2025
Prodrug salts2025
Pyrrolo-dipyridine compounds2025
Substituted tetrahydroquinolin compounds as indoleamine 2,3-dioxygenase (IDO) in2024
Arylalkyl pyrazole compounds as indoleamine 2,3-dioxygenase inhibitors2024
Benzimidazole derivatives as dual histamine H1 and histamine H4 receptor ligands2024
Substituted pyrazole compounds as indoleamine 2,3-dioxygenase inhibitors2024